|
Orthologous residues
|
|
APP (human): Y757‑p, APP iso4 (human): Y682‑p, APP iso8 (human): Y738‑p, APP (mouse): Y757‑p, APP iso2 (mouse): Y682‑p, APP (rat): Y757‑p, APP iso2 (rat): Y682‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
immunoprecipitation, microscopy-colocalization with upstream kinase, mutation of modification site, western blotting
|
|
Disease tissue studied:
Alzheimer's disease
|
|
Relevant cell lines - cell types - tissues:
'brain, hippocampus' [APP (mouse), genetic knockin], neuron-'brain, hippocampus' [APP (mouse), genetic knockin]
|
|
Cellular systems studied:
primary cultured cells, tissue
|
|
Species studied:
mouse
|
|
Comments:
APP YG/YG mice
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
TrkA (mouse)
|
activation of upstream enzyme, microscopy-colocalization, co-immunoprecipitation, pharmacological inhibitor of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
NGF
|
|
|
|
increase
|
|
|
|
|